Vaxcell-Bio Therapeutics Co., Ltd. (KOSDAQ:323990)
5,070.00
+1,065.00 (26.59%)
Sep 1, 2026, 3:30 PM KST
-43.29% (1Y)
| Market Cap | 117.91B -43.3% |
| Revenue (ttm) | n/a +13,737.3% |
| Net Income | n/a |
| EPS | n/a |
| Shares Out | 23.26M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 544,301 |
| Open | 3,925.00 |
| Previous Close | 4,005.00 |
| Day's Range | 3,910.00 - 5,190.00 |
| 52-Week Range | 3,350.00 - 11,520.00 |
| Beta | 0.71 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |